Skip to main content

Peer Review reports

From: Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review

Original Submission
8 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Jul 2022 Reviewed Reviewer Report
3 Aug 2022 Reviewed Reviewer Report
12 Oct 2022 Reviewed Reviewer Report
17 Nov 2022 Reviewed Reviewer Report
5 Dec 2022 Author responded Author comments - Bei Li
Resubmission - Version 3
5 Dec 2022 Submitted Manuscript version 3
8 Dec 2022 Author responded Author comments - Bei Li
Resubmission - Version 4
8 Dec 2022 Submitted Manuscript version 4
8 Dec 2022 Author responded Author comments - Bei Li
Resubmission - Version 5
8 Dec 2022 Submitted Manuscript version 5
23 Dec 2022 Reviewed Reviewer Report
16 Jan 2023 Author responded Author comments - Bei Li
Resubmission - Version 6
16 Jan 2023 Submitted Manuscript version 6
1 Feb 2023 Reviewed Reviewer Report
2 Feb 2023 Author responded Author comments - Bei Li
Resubmission - Version 7
2 Feb 2023 Submitted Manuscript version 7
3 Feb 2023 Author responded Author comments - Bei Li
Resubmission - Version 8
3 Feb 2023 Submitted Manuscript version 8
22 Feb 2023 Reviewed Reviewer Report
24 Feb 2023 Author responded Author comments - Bei Li
Resubmission - Version 9
24 Feb 2023 Submitted Manuscript version 9
Publishing
27 Feb 2023 Editorially accepted
25 Apr 2023 Article published 10.1186/s12885-023-10679-8

You can find further information about peer review here.

Back to article page